We read with great interest the paper “Owner assessment of the outcome of tibial plateau levelling osteotomy without meniscal evaluation for treatment of naturally occurring cranial cruciate ligament ruptures: 130 cases (2009 to 2013)” by S. Bureau, and we commend Dr Bureau on the effort to collate data and publish results. However, there are some aspects of the paper that should be discussed openly in an effort to glean more useful clinical relevance to our everyday population of dogs with cruciate disease that we treat. The discussion of meniscal pathology in people is of interest and deserves some mention, but its relevance to the clinical situation in dogs is very limited. The majority of meniscal injuries in humans are isolated and/or degenerative meniscal tears that are not associated with an unstable knee. Meniscal lesions associated with knee instability are treated surgically as a significant comorbidity at the time of knee stabilisation as the current standard-of-care in orthopaedics. Therefore, Dr Bureau’s suggestion that non-surgical treatment of canine meniscal lesions associated with instability is justified based on practice in human orthopaedics is not valid. While we can agree that there may be some meniscal lesions that do not cause lameness in dogs with pre-existing osteoarthritis and stifle instability, we feel that veterinary health care providers should be making efforts to better define this subpopulation rather than suggesting that we can ignore the meniscus altogether. Best current evidence suggests that addressing meniscal lesions alone can provide benefit (Tivers et al. 2009) in dogs with naturally occurring cranial cruciate ligament disease, and by the author’s own admission in this paper, 6% of dogs had a persistent lameness suspected to be caused by concurrent meniscal injury. While this rate of postoperative lameness appeared to be acceptable to the author, we advocate strongly against subjecting dogs and clients to disability and costs that can be addressed by standard-of-practice care at the time of the index major surgical procedure. It is undoubtedly true that both arthroscopy and mini medial arthrotomy do cause some degree of morbidity and that, in completely normal stifles, arthrotomy and partial meniscectomy will cause some degree of osteoarthritis. However, this justification is also misapplied by the author in that the population of dogs included in this paper did not have normal stifles. In contrast, all dogs in the study had full-thickness cranial cruciate ruptures with secondary osteoarthritis as defined by the criteria for inclusion. In addition, the morbidity of arthroscopy or mini medial arthrotomy is certainly not greater than osteotomy and open reduction and internal fixation. Therefore, the author’s inference that stifle examination, whether by mini medial arthrotomy or preferably arthroscopy in the hands of a trained surgeon, poses greater risk than benefit to the patient is completely unsubstantiated. This is further supported by extensive peer-reviewed evidence, including the author’s own data, which show that the risk of non-treatment detrimentally affected at least 9% of Dr Bureau’s patients (6% of dogs with persistent lameness after index surgery and a further 3% that went on to develop late meniscal injury). We believe this to be unacceptably high when examining best current evidence showing that complete joint assessment and meniscal treatment at the index surgery can significantly reduce the incidence of late-onset meniscal pathology (Thieman et al. 2006, Christopher et al. 2013, Ritzo et al. 2014). Furthermore, it is likely that 9% underestimates the actual proportion of dogs affected by unaddressed meniscal lesions based on the subjective nature of the assessments in the study in conjunction with the subpopulation of dogs that were reported to have chronic lameness. A number of dogs in this subpopulation may well have had meniscal lesions, which may have improved their outcome if addressed. Cases 83, 85 and 103 were defined as having a reduced range of movement, which has been associated with meniscal injury. The importance of assessing and treating the meniscus in dogs with cranial cruciate ligament disease has been known for decades and repeatedly validated in evidence-based studies. Meniscal-related complications occur with high incidence following any form of stifle stabilisation surgery when the meniscus is not addressed at the index surgery (Christopher et al. 2013; Ritzo et al. 2014; and many others). To intentionally ignore the meniscus during a major surgical intervention designed to relieve stifle joint symptoms and improve stifle joint function cannot be justified based on the extensive body of evidence in the peer-reviewed literature. By ignoring the meniscus, the rest of the joint is also left at risk. Cranial cruciate ligament failure is an articular disease. So, not making a complete assessment of the joint is, by definition, neglecting the primary problem. In addition to reducing the incidence of subsequent meniscal-related complications, achieving a complete joint assessment of the diseased stifle allows diagnosis and treatment of other pathologies documented to occur with cranial cruciate ligament disease and affect outcome; documents the status of the joint for staging, prognostic and legal purposes; and provides clients with the complete information about their pet’s medical condition that they deserve. These benefits clearly outweigh the minimal risk and morbidity that the author is concerned about. In summary, we feel that Dr Bureau’s important study should be used to push us forward in taking a more comprehensive approach to best current practice for treatment of cranial cruciate ligament disease in dogs. The peer-reviewed evidence is clear in documenting that the meniscus cannot, in fact, be ignored if veterinary surgeons seek to provide optimal outcomes for our patients. We fear that the findings of this paper may be used to justify suboptimal care, which is irresponsible and potentially dangerous. We will only learn more and improve by looking more closely, not by closing our eyes. Our patients and clients deserve that. Both authors are paid consultants to Arthrex. PR is paid to teach arthroscopy by Arthrex. JC is also a consultant to Eli Lilly, Merial and ConMed and holds unrelated patents with Arthrex and University of Missouri. JC is also on the Editorial Board for Journal of Knee.